Oxaliplatin-induced haemolytic anaemia

A case of haemolytic anaemia after therapy with oxaliplatin, an anticancer chemotherapeutic agent, was investigated. Haemolytic anaemia has been associated with cisplatin and carboplatin, two related drugs, but not with oxaliplatin.

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 1999-10, Vol.354 (9185), p.1179-1180
Main Authors: Desrame, J, Broustet, H, de Tailly, P Darodes, Girard, D, Saissy, JM
Format: Article
Language:English
Subjects:
Adenocarcinoma - drug therapy
Adenocarcinoma - secondary
Aged
Anemia
Anemia, Hemolytic - chemically induced
Anticancer properties
Antineoplastic Agents - adverse effects
Antineoplastic Agents - blood
Back pain
Biological and medical sciences
Blood
Carboplatin
Chemotherapy
Cisplatin
Colorectal Neoplasms - pathology
Drug therapy
Drug toxicity and drugs side effects treatment
Fatal Outcome
Female
Hemolytic anemia
Humans
Liver Neoplasms - drug therapy
Liver Neoplasms - secondary
Medical research
Medical sciences
Organoplatinum Compounds - adverse effects
Organoplatinum Compounds - blood
Oxaliplatin
Pharmacology. Drug treatments
Prescription drugs
Toxicity: blood
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A case of haemolytic anaemia after therapy with oxaliplatin, an anticancer chemotherapeutic agent, was investigated. Haemolytic anaemia has been associated with cisplatin and carboplatin, two related drugs, but not with oxaliplatin.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(99)03827-1